Consolidated Statements of Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit) (Parentheticals) - Total Onconetix Equity (Deficit) |
12 Months Ended |
|---|---|
|
Dec. 31, 2022
USD ($)
| |
| Issuance of common stock in initial public offering, net | $ 2.9 |
| Issuance of common stock and warrants in April private placement, net | 1.1 |
| Issuance of common stock and warrants in August private placement, net | $ 2.2 |